Mankind Pharma Limited
Aditya Birla Sun Life Mutual Fund now holds a 1.21% stake in Mankind Pharma Limited, up from under 1%, after being newly named in the latest shareholding filing with 49,97,240 shares.
A pharmaceutical company that develops, manufactures, and markets a diverse range of formulations across acute and chronic therapeutic areas alongside consumer healthcare products. Incorporated in 1995, the company operates through multiple distribution channels and disease segments within India's pharmaceutical market. Its portfolio spans prescription medicines, over-the-counter products, and wellness offerings designed to serve diverse patient populations and healthcare needs.
Joint venture between Aditya Birla Capital and Sun Life Financial of Canada. Among India's top five AMCs with over Rs 6.5 lakh crore in AUM across 100+ schemes. MD and CEO A. Balasubramanian is one of the most outspoken fund industry voices in India. CIO Mahesh Patil oversees the equity book with a consistent large and multicap tilt.